Charles Rhyee
Stock Analyst at TD Cowen
(1.04)
# 3,717
Out of 4,944 analysts
53
Total ratings
40%
Success rate
-10.51%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Downgrades: Sell | $283 → $366 | $468.32 | -21.85% | 5 | Jul 23, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $176.41 | -11.00% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $148.12 | -2.78% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $155.04 | +46.41% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $7.84 | +218.88% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $7.44 | +7.53% | 6 | Oct 31, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $279.18 | -31.23% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $3.56 | +349.44% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.58 | +93.80% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $7.19 | +595.41% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $190.23 | +31.95% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $7.68 | +629.17% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.45 | +3,046.07% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $8.97 | +457.41% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $663.17 | -45.56% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $0.43 | +760,106.48% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $24.53 | +42.71% | 1 | Feb 13, 2018 |
Medpace Holdings
Jul 23, 2025
Downgrades: Sell
Price Target: $283 → $366
Current: $468.32
Upside: -21.85%
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $176.41
Upside: -11.00%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $148.12
Upside: -2.78%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $155.04
Upside: +46.41%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $7.84
Upside: +218.88%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $7.44
Upside: +7.53%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $279.18
Upside: -31.23%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $3.56
Upside: +349.44%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.58
Upside: +93.80%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $7.19
Upside: +595.41%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $190.23
Upside: +31.95%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $7.68
Upside: +629.17%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.45
Upside: +3,046.07%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $8.97
Upside: +457.41%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $663.17
Upside: -45.56%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $0.43
Upside: +760,106.48%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $24.53
Upside: +42.71%